Serveur d'exploration Épistémè

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Social Sciences for the Prevention of Blindness

Identifieur interne : 000017 ( Pmc/Corpus ); précédent : 000016; suivant : 000018

Social Sciences for the Prevention of Blindness

Auteurs : Pablo Goldschmidt

Source :

RBID : PMC:4491490

Abstract

Organizations working for the elimination of Chlamydia-triggered blindness (trachoma) follow the WHO SAFE strategy (surgery for trichiasis, antibiotics, face washing and environmental changes) with the aim to achieve a minimum of 80% of children with clean faces in endemic communities, mass treatment covering the whole district with trachoma rates of 10% or more and surveillance plans.

Trachoma recurrence that is common after implementing the SAFE strategy 3, 5 or even 7 times evidence that the cognitive processes requiring assimilation and integration of knowledge did not register with parents, caretakers and children. Moreover, repeated awareness campaigns to improve hygiene did not systematically produce irreversible changes of behavior in neglected populations. In view of this evidence, the rational behind mass drug administration as the mainstay of preventable blindness elimination demands a wider scope than simple mathematical models. The reluctance to see disappointing outcomes that leads to repeated interventions may suggest from a sociologic point of view that the strategies are products of those evaluating the activities of those who fund them and vice versa. A similar articulation emerges for reciprocal interactions between researchers and those judging the pertinence and quality of their work. So far, the lack of autocritic elimination strategy approaches may expose inbred circles that did not properly grasp the fact that antibiotics, trichiasis surgery and education limited to improvement of hygiene are inefficient if not associated with long-term basic educational actions in schools.


Url:
DOI: 10.2149/tmh.2014-32
PubMed: 26161032
PubMed Central: 4491490

Links to Exploration step

PMC:4491490

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Social Sciences for the Prevention of Blindness</title>
<author>
<name sortKey="Goldschmidt, Pablo" sort="Goldschmidt, Pablo" uniqKey="Goldschmidt P" first="Pablo" last="Goldschmidt">Pablo Goldschmidt</name>
<affiliation>
<nlm:aff id="aff1">
<institution>Laboratorie du Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts</institution>
,
<addr-line>28, rue de Charenton, Paris 75012, France</addr-line>
</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">26161032</idno>
<idno type="pmc">4491490</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491490</idno>
<idno type="RBID">PMC:4491490</idno>
<idno type="doi">10.2149/tmh.2014-32</idno>
<date when="2015">2015</date>
<idno type="wicri:Area/Pmc/Corpus">000017</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000017</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Social Sciences for the Prevention of Blindness</title>
<author>
<name sortKey="Goldschmidt, Pablo" sort="Goldschmidt, Pablo" uniqKey="Goldschmidt P" first="Pablo" last="Goldschmidt">Pablo Goldschmidt</name>
<affiliation>
<nlm:aff id="aff1">
<institution>Laboratorie du Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts</institution>
,
<addr-line>28, rue de Charenton, Paris 75012, France</addr-line>
</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Tropical Medicine and Health</title>
<idno type="ISSN">1348-8945</idno>
<idno type="eISSN">1349-4147</idno>
<imprint>
<date when="2015">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>Organizations working for the elimination of
<italic>Chlamydia</italic>
-triggered blindness (trachoma) follow the WHO SAFE strategy (surgery for trichiasis, antibiotics, face washing and environmental changes) with the aim to achieve a minimum of 80% of children with clean faces in endemic communities, mass treatment covering the whole district with trachoma rates of 10% or more and surveillance plans. </p>
<p id="p001">Trachoma recurrence that is common after implementing the SAFE strategy 3, 5 or even 7 times evidence that the cognitive processes requiring assimilation and integration of knowledge did not register with parents, caretakers and children. Moreover, repeated awareness campaigns to improve hygiene did not systematically produce irreversible changes of behavior in neglected populations. In view of this evidence, the rational behind mass drug administration as the mainstay of preventable blindness elimination demands a wider scope than simple mathematical models. The reluctance to see disappointing outcomes that leads to repeated interventions may suggest from a sociologic point of view that the strategies are products of those evaluating the activities of those who fund them and vice versa. A similar articulation emerges for reciprocal interactions between researchers and those judging the pertinence and quality of their work. So far, the lack of autocritic elimination strategy approaches may expose inbred circles that did not properly grasp the fact that antibiotics, trichiasis surgery and education limited to improvement of hygiene are inefficient if not associated with long-term basic educational actions in schools.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ngondi, J" uniqKey="Ngondi J">J Ngondi</name>
</author>
<author>
<name sortKey="Reacher, M" uniqKey="Reacher M">M Reacher</name>
</author>
<author>
<name sortKey="Matthews, F" uniqKey="Matthews F">F Matthews</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Goldschmidt, P" uniqKey="Goldschmidt P">P Goldschmidt</name>
</author>
<author>
<name sortKey="Rostane, H" uniqKey="Rostane H">H Rostane</name>
</author>
<author>
<name sortKey="Sow, M" uniqKey="Sow M">M Sow</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Barr, K" uniqKey="Barr K">K Barr</name>
</author>
<author>
<name sortKey="Essex, Rw" uniqKey="Essex R">RW Essex</name>
</author>
<author>
<name sortKey="Liu, S" uniqKey="Liu S">S Liu</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="West, S" uniqKey="West S">S West</name>
</author>
<author>
<name sortKey="Munoz, B" uniqKey="Munoz B">B Munoz</name>
</author>
<author>
<name sortKey="Mkocha, H" uniqKey="Mkocha H">H Mkocha</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lietman, Tm" uniqKey="Lietman T">TM Lietman</name>
</author>
<author>
<name sortKey="Gebre, T" uniqKey="Gebre T">T Gebre</name>
</author>
<author>
<name sortKey="Ayele, B" uniqKey="Ayele B">B Ayele</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Abdou, A" uniqKey="Abdou A">A Abdou</name>
</author>
<author>
<name sortKey="Munoz, B" uniqKey="Munoz B">B Munoz</name>
</author>
<author>
<name sortKey="Nassirou, B" uniqKey="Nassirou B">B Nassirou</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gambhir, M" uniqKey="Gambhir M">M Gambhir</name>
</author>
<author>
<name sortKey="Basa Ez, Mg" uniqKey="Basa Ez M">MG Basáñez</name>
</author>
<author>
<name sortKey="Blake, Im" uniqKey="Blake I">IM Blake</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lavett, D" uniqKey="Lavett D">D Lavett</name>
</author>
<author>
<name sortKey="Lansingh, V" uniqKey="Lansingh V">V Lansingh</name>
</author>
<author>
<name sortKey="Carter, M" uniqKey="Carter M">M Carter</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Matzneller, P" uniqKey="Matzneller P">P Matzneller</name>
</author>
<author>
<name sortKey="Krasniqi, S" uniqKey="Krasniqi S">S Krasniqi</name>
</author>
<author>
<name sortKey="Kinzig, M" uniqKey="Kinzig M">M Kinzig</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Burton, Mj" uniqKey="Burton M">MJ Burton</name>
</author>
<author>
<name sortKey="Frick, Kd" uniqKey="Frick K">KD Frick</name>
</author>
<author>
<name sortKey="Bailey, Rl" uniqKey="Bailey R">RL Bailey</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Goldschmidt, P" uniqKey="Goldschmidt P">P Goldschmidt</name>
</author>
<author>
<name sortKey="Einterz, E" uniqKey="Einterz E">E Einterz</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hong, Kc" uniqKey="Hong K">KC Hong</name>
</author>
<author>
<name sortKey="Schachter, J" uniqKey="Schachter J">J Schachter</name>
</author>
<author>
<name sortKey="Moncada, J" uniqKey="Moncada J">J Moncada</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Bhengraj, Ar" uniqKey="Bhengraj A">AR Bhengraj</name>
</author>
<author>
<name sortKey="Srivastava, P" uniqKey="Srivastava P">P Srivastava</name>
</author>
<author>
<name sortKey="Mittal, A" uniqKey="Mittal A">A Mittal</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Card, Rm" uniqKey="Card R">RM Card</name>
</author>
<author>
<name sortKey="Warburton, Pj" uniqKey="Warburton P">PJ Warburton</name>
</author>
<author>
<name sortKey="Maclaren, N" uniqKey="Maclaren N">N Maclaren</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Roba, A" uniqKey="Roba A">A Roba</name>
</author>
<author>
<name sortKey="Patel, D" uniqKey="Patel D">D Patel</name>
</author>
<author>
<name sortKey="Zondervan, D" uniqKey="Zondervan D">D Zondervan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Evans, Jr" uniqKey="Evans J">JR Evans</name>
</author>
<author>
<name sortKey="Solomon, Aw" uniqKey="Solomon A">AW Solomon</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Munoz, B" uniqKey="Munoz B">B Munoz</name>
</author>
<author>
<name sortKey="Stare, D" uniqKey="Stare D">D Stare</name>
</author>
<author>
<name sortKey="Mkocha, H" uniqKey="Mkocha H">H Mkocha</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Stoller, N" uniqKey="Stoller N">N Stoller</name>
</author>
<author>
<name sortKey="Gebre, T" uniqKey="Gebre T">T Gebre</name>
</author>
<author>
<name sortKey="Ayele, B" uniqKey="Ayele B">B Ayele</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Dolin, P" uniqKey="Dolin P">P Dolin</name>
</author>
<author>
<name sortKey="Faal, H" uniqKey="Faal H">H Faal</name>
</author>
<author>
<name sortKey="Johnson, Gj" uniqKey="Johnson G">GJ Johnson</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Burton, M" uniqKey="Burton M">M Burton</name>
</author>
<author>
<name sortKey="Holland, M" uniqKey="Holland M">M Holland</name>
</author>
<author>
<name sortKey="Makalo, P" uniqKey="Makalo P">P Makalo</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Yee, A" uniqKey="Yee A">A Yee</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ejere, Ho" uniqKey="Ejere H">HO Ejere</name>
</author>
<author>
<name sortKey="Alhassan, Mb" uniqKey="Alhassan M">MB Alhassan</name>
</author>
<author>
<name sortKey="Rabiu, M" uniqKey="Rabiu M">M Rabiu</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Travers, A" uniqKey="Travers A">A Travers</name>
</author>
<author>
<name sortKey="Strasser, S" uniqKey="Strasser S">S Strasser</name>
</author>
<author>
<name sortKey="Palmer, Sl" uniqKey="Palmer S">SL Palmer</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kiesecker, J" uniqKey="Kiesecker J">J Kiesecker</name>
</author>
<author>
<name sortKey="Skelly, D" uniqKey="Skelly D">D Skelly</name>
</author>
<author>
<name sortKey="Beard, K" uniqKey="Beard K">K Beard</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lomas, J" uniqKey="Lomas J">J Lomas</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Devisch, I" uniqKey="Devisch I">I Devisch</name>
</author>
<author>
<name sortKey="Murray, Sj" uniqKey="Murray S">SJ Murray</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rabiu, M" uniqKey="Rabiu M">M Rabiu</name>
</author>
<author>
<name sortKey="Alhassan, M" uniqKey="Alhassan M">M Alhassan</name>
</author>
<author>
<name sortKey="Ejere, H" uniqKey="Ejere H">H Ejere</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sigdel, R" uniqKey="Sigdel R">R Sigdel</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Harvey, J" uniqKey="Harvey J">J Harvey</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hart, E" uniqKey="Hart E">E Hart</name>
</author>
<author>
<name sortKey="Hazelgrove, J" uniqKey="Hazelgrove J">J Hazelgrove</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Horta, H" uniqKey="Horta H">H Horta</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Langfeldt, L" uniqKey="Langfeldt L">L Langfeldt</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Boix Mansilla, V" uniqKey="Boix Mansilla V">V Boix-Mansilla</name>
</author>
<author>
<name sortKey="Feller, I" uniqKey="Feller I">I Feller</name>
</author>
<author>
<name sortKey="Gardner, H" uniqKey="Gardner H">H Gardner</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Patterson, G" uniqKey="Patterson G">G Patterson</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Basak, R" uniqKey="Basak R">R Basak</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Grossman, L" uniqKey="Grossman L">L Grossman</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Stein, R" uniqKey="Stein R">R Stein</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="review-article">
<pmc-dir>properties open_access</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Trop Med Health</journal-id>
<journal-id journal-id-type="publisher-id">TMH</journal-id>
<journal-title-group>
<journal-title>Tropical Medicine and Health</journal-title>
</journal-title-group>
<issn pub-type="ppub">1348-8945</issn>
<issn pub-type="epub">1349-4147</issn>
<publisher>
<publisher-name>The Japanese Society of Tropical Medicine</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26161032</article-id>
<article-id pub-id-type="pmc">4491490</article-id>
<article-id pub-id-type="publisher-id">JST.JSTAGE/tmh/2014-32</article-id>
<article-id pub-id-type="doi">10.2149/tmh.2014-32</article-id>
<article-id pub-id-type="publisher-manuscript">2014-32</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reviews and Opinions</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Social Sciences for the Prevention of Blindness</article-title>
<alt-title alt-title-type="left-running-head"></alt-title>
<alt-title alt-title-type="right-running-head"></alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Goldschmidt</surname>
<given-names>Pablo</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<aff id="aff1">
<label>1</label>
<institution>Laboratorie du Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts</institution>
,
<addr-line>28, rue de Charenton, Paris 75012, France</addr-line>
</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Tel: +33140021694 Fax: +33140021699 E-mail:
<email xlink:href="pablogol@aol.com">pablogol@aol.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>6</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>25</day>
<month>3</month>
<year>2015</year>
</pub-date>
<volume>43</volume>
<issue>2</issue>
<fpage>141</fpage>
<lpage>148</lpage>
<history>
<date date-type="received">
<day>27</day>
<month>10</month>
<year>2014</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>3</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>2015 Japanese Society of Tropical Medicine</copyright-statement>
<copyright-year>2015</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<p>Organizations working for the elimination of
<italic>Chlamydia</italic>
-triggered blindness (trachoma) follow the WHO SAFE strategy (surgery for trichiasis, antibiotics, face washing and environmental changes) with the aim to achieve a minimum of 80% of children with clean faces in endemic communities, mass treatment covering the whole district with trachoma rates of 10% or more and surveillance plans. </p>
<p id="p001">Trachoma recurrence that is common after implementing the SAFE strategy 3, 5 or even 7 times evidence that the cognitive processes requiring assimilation and integration of knowledge did not register with parents, caretakers and children. Moreover, repeated awareness campaigns to improve hygiene did not systematically produce irreversible changes of behavior in neglected populations. In view of this evidence, the rational behind mass drug administration as the mainstay of preventable blindness elimination demands a wider scope than simple mathematical models. The reluctance to see disappointing outcomes that leads to repeated interventions may suggest from a sociologic point of view that the strategies are products of those evaluating the activities of those who fund them and vice versa. A similar articulation emerges for reciprocal interactions between researchers and those judging the pertinence and quality of their work. So far, the lack of autocritic elimination strategy approaches may expose inbred circles that did not properly grasp the fact that antibiotics, trichiasis surgery and education limited to improvement of hygiene are inefficient if not associated with long-term basic educational actions in schools.</p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>Chlamydia</kwd>
<kwd>trachoma elimination</kwd>
<kwd>antibiotics</kwd>
<kwd>hygiene</kwd>
<kwd>SAFE</kwd>
<kwd>sociology</kwd>
<kwd>inbred</kwd>
<kwd>scholasticism</kwd>
<kwd>education</kwd>
<kwd>schooling</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec>
<title>Effectiveness of Funding in Organizations Working to Eliminate Preventable Blindness</title>
<p id="p002">Trachoma is one of the oldest bacterial diseases known to humans and yet today remains the world’s leading cause of preventable blindness. Globally, 1,2 billion people live in endemic regions, many in poor rural areas with limited access to sanitation and basic education [
<xref rid="B1" ref-type="bibr">1</xref>
]. The World Health Organization (WHO) estimates that more than six million people are blinded by trachoma [
<xref rid="B1" ref-type="bibr">1</xref>
,
<xref rid="B2" ref-type="bibr">2</xref>
].</p>
<p id="p003">The conjunctival inflammation triggered by the intracellular bacteria
<italic>Chlamydia</italic>
leads to trachoma, especially in people living in conditions of extreme poverty [
<xref rid="B2" ref-type="bibr">2</xref>
]. The early signs of active trachoma are diagnosed by everting the upper eyelid, while the presence of
<italic>Chlamydia</italic>
in conjunctival cells is assessed using nucleic-acid amplification techniques (PCR) [
<xref rid="B2" ref-type="bibr">2</xref>
<xref rid="B4" ref-type="bibr">4</xref>
]. Repeated or chronic infections with
<italic>Chlamydia</italic>
may result in scarring of the eyelid, and the in-turned lashes rubbing the globe (trichiasis) may provoke corneal scarring and blindness.</p>
<p id="p004">For the elimination of trachoma, the World Health Organization (WHO) established the SAFE strategy based on the implementation of four components: surgery for trichiasis (S), administration of active antibiotics to kill
<italic>Chlamydia</italic>
(A), face washing (F) and environmental changes (E) [
<xref rid="B1" ref-type="bibr">1</xref>
<xref rid="B3" ref-type="bibr">3</xref>
,
<xref rid="B5" ref-type="bibr">5</xref>
]. Surgical correction of trichiasis is an integral part of the WHO effort to eliminate blindness from trachoma by the year 2020. However, the recurrence rates following surgery for trichiasis have been reported to be disappointingly high [
<xref rid="B6" ref-type="bibr">6</xref>
].</p>
</sec>
<sec>
<title>Understanding Structure, Function and Effectiveness of Actions for the Prevention of Evitable Blindness from Bacterial Origin</title>
<p id="p005">Presently, the governmental and non-governmental organizations working for the elimination of trachoma concentrate their efforts on following the SAFE strategy. Their aim is to achieve a) a minimum of 80% of children (1–9 years old) with clean faces in the endemic communities; b) mass treatment of the entire district with follicular trachoma rates of 10% or more (WHO recommends repeated interventions with at least three repeated rounds of antibiotics and impact surveys regardless of whether or not villages had initial low prevalence rates) [
<xref rid="B5" ref-type="bibr">5</xref>
,
<xref rid="B7" ref-type="bibr">7</xref>
,
<xref rid="B8" ref-type="bibr">8</xref>
], and c) the development and implementation of surveillance plans in countries that have reached their ultimate intervention goals [
<xref rid="B9" ref-type="bibr">9</xref>
<xref rid="B11" ref-type="bibr">11</xref>
].</p>
<p id="p006">Several private corporations in the U.S.A. have a strong tradition as funding organizations for the promotion of medical care. These organizations support patient advocacy groups, professional medical associations and charitable organizations in the 501(c) tax status environment (donations contribute to lower tax bills). The legitimate tax deduction must be addressed to a qualified organization, and to be tax-exempt under section 501(c) of the Internal Revenue Code, none of the organization earnings may inure any private individual, nor may the organization influence legislation as part of its activities or participate in any activity for or against political candidates. The organizations described in section 501(c) must not be organized or operated for private interests and are commonly referred to as “charitable organizations” [
<xref rid="B12" ref-type="bibr">12</xref>
].</p>
<p id="p007">The funding of not-for-profit organization programs eligible for healthcare contributions target health screening, advocacy of disease awareness, patient access to medical care and patient education for hygiene. The vast majority of the institutions committed to the fight against preventable blindness are outlined below (Table
<xref ref-type="table" rid="T1">1</xref>
).</p>
<p id="p008">In 2013, the Alliance for the Global Elimination of Blinding Trachoma by the Year 2020 recognized the need for a) surveys at the sub-district as well as district level; b) improved laboratory tests for
<italic>Chlamydia</italic>
; c) post-endemic surveillance in urban areas with unoperated trichiasis; d) improvement and standardization of surgical procedures to minimize trichiasis recurrence and e) cost assessment for achieving high massive drug administration [
<xref rid="B2" ref-type="bibr">2</xref>
,
<xref rid="B13" ref-type="bibr">13</xref>
]. Presently, more than 225 million doses donated by Pfizer have been distributed since the start of the drug donation program in 1998. Moreover, the neglected Tropical Disease Nongovernmental Development Organizations Network (NTD NGDO) [
<xref rid="B31" ref-type="bibr">31</xref>
] and its public-private partnerships facilitates among other actions, the distribution of antibiotics (Table
<xref ref-type="table" rid="T2">2</xref>
).</p>
</sec>
<sec>
<title>Limitations of Medical Interventions for the Elimination of Trachoma</title>
<p id="p009">As largely reported, the antibiotic (azithromycin) administered to treat trachoma is bioavailable and highly active against the intracellular microorganisms triggering trachoma (
<italic>Chlamydiae</italic>
) [
<xref rid="B41" ref-type="bibr">41</xref>
,
<xref rid="B42" ref-type="bibr">42</xref>
]. This antibiotic eradicates
<italic>Chlamydia</italic>
from the conjunctival cells in a few weeks and dramatically reduces the clinical signs of active trachoma (follicles in the conjunctiva) [
<xref rid="B8" ref-type="bibr">8</xref>
,
<xref rid="B9" ref-type="bibr">9</xref>
,
<xref rid="B43" ref-type="bibr">43</xref>
]. Moreover, azithromycin treatments revealed no evidence that
<italic>Chlamydiae</italic>
lost their susceptibility to this antibiotic by post-transcriptional methylation of the 23S bacterial ribosomal-RNA, either plasmid or chromosome-mediated [
<xref rid="B44" ref-type="bibr">44</xref>
,
<xref rid="B45" ref-type="bibr">45</xref>
]. In addition, people treated for trachoma have never shown
<italic>Chlamydia trachomatis</italic>
susceptibility-reduction associated either with enzymes (esterase or kinase) that inactivate azithromycin or with the synthesis of efflux proteins that drain this antibiotic outside of the bacteria [
<xref rid="B45" ref-type="bibr">45</xref>
,
<xref rid="B46" ref-type="bibr">46</xref>
].</p>
<p id="p010">Globally, the heterogeneity of clinical trials makes it inappropriate to analyze data on the four components of the SAFE strategy. In fact, 14 trials that included 3,587 participants and 15 trials that included 8,678 did not allow highlighting of the real impact of antibiotic treatment on the long-term elimination of clinical active trachoma, showing first, that clinical signs of trachoma re-emerged in treated communities, and second, that
<italic>Chlamydia</italic>
genomes were detected in conjunctival samples after repeated implementation of the four components of the SAFE strategy. The evidence at this point suggests that trachoma was partially reduced but not eliminated by repeatedly implementing the WHO strategy [
<xref rid="B43" ref-type="bibr">43</xref>
,
<xref rid="B47" ref-type="bibr">47</xref>
<xref rid="B49" ref-type="bibr">49</xref>
]. These facts suggest that the microbiological episteme makes it unreasonable to justify the repeated administration of active antibiotics in the same district to the same people (5, 7, 9 times or even more) to treat susceptible germs, and therefore that further analysis cannot be restricted to mathematical predictors, laboratory results or the opinions of eye-surface specialists [
<xref rid="B11" ref-type="bibr">11</xref>
,
<xref rid="B43" ref-type="bibr">43</xref>
,
<xref rid="B49" ref-type="bibr">49</xref>
,
<xref rid="B50" ref-type="bibr">50</xref>
]. At this point, special attention should be paid to efforts made in Morocco, Oman, Nepal and Gambia for the elimination of preventable blindness from bacterial origin. In these countries, surprisingly, the dramatic decrease in trachoma was the result of strong government commitments to basic education supported by health-care institutions, with or without implementing the SAFE strategy [
<xref rid="B51" ref-type="bibr">51</xref>
<xref rid="B54" ref-type="bibr">54</xref>
].</p>
</sec>
<sec>
<title>F and E: Face Washing and Environmental Improvement and the Role of Social Sciences in the Elimination of Preventable Diseases</title>
<p id="p011">In trachoma elimination strategy, dirty faces in children have been cited as the main pathway by which
<italic>Chlamydia</italic>
spreads in people with ocular and nasal discharge [
<xref rid="B2" ref-type="bibr">2</xref>
,
<xref rid="B55" ref-type="bibr">55</xref>
,
<xref rid="B56" ref-type="bibr">56</xref>
]. The components F and E of the SAFE strategy are founded on the idea that instruction on hygiene during the promotion of sanitation is the fundamental behavioral key to trachoma elimination. Accordingly, the dissemination of information about cleanliness (F and E components) was expected to produce massive behavioral changes and a comprehensive understanding of the factors encouraging the transmission of germs [
<xref rid="B57" ref-type="bibr">57</xref>
,
<xref rid="B58" ref-type="bibr">58</xref>
]. Nevertheless, trachoma recurrence is frequent in districts in which all the SAFE components were implemented, and the limited success of the F and E components (after awareness campaigns) sounds a warning about the inefficient transmission of knowledge and the lack of integration of risk factors into people’s daily activities. The frequency of dirty faces persisting after the SAFE strategy shows that the cognitive processes requiring assimilation and integration of knowledge did not register with parents, care takers and children [
<xref rid="B55" ref-type="bibr">55</xref>
,
<xref rid="B59" ref-type="bibr">59</xref>
,
<xref rid="B60" ref-type="bibr">60</xref>
]: only one out of three studies (SAFE strategy) shows significant results for the reduction of trachoma prevalence after conveying information on the need for improved hygiene [
<xref rid="B11" ref-type="bibr">11</xref>
,
<xref rid="B47" ref-type="bibr">47</xref>
,
<xref rid="B61" ref-type="bibr">61</xref>
,
<xref rid="B62" ref-type="bibr">62</xref>
].</p>
</sec>
<sec>
<title>Social Research to Supplement Medical Approaches</title>
<p id="p012">It was reasonable to expect the elimination of antibiotic-susceptible bacteria triggering the chronic inflammatory conjunctival processes that lead to blindness after implementation of all four components of the SAFE strategy (once or repeatedly). In reality, however, trachoma was neither irreversibly eliminated nor prevented, and recurrences required a repetition of pharmacologic interventions seven or even more times [
<xref rid="B10" ref-type="bibr">10</xref>
,
<xref rid="B11" ref-type="bibr">11</xref>
,
<xref rid="B43" ref-type="bibr">43</xref>
,
<xref rid="B48" ref-type="bibr">48</xref>
,
<xref rid="B63" ref-type="bibr">63</xref>
].</p>
<p id="p013">Social sciences may help to identify factors that shape organizational error regarding concepts understood not as purely academic but for their ethical relevance [
<xref rid="B64" ref-type="bibr">64</xref>
,
<xref rid="B65" ref-type="bibr">65</xref>
]. Several organizations with high ethical ideals assisted in efforts to help not-for-profit institutions working for the elimination of preventable blindness in neglected populations [
<xref rid="B1" ref-type="bibr">1</xref>
,
<xref rid="B2" ref-type="bibr">2</xref>
,
<xref rid="B13" ref-type="bibr">13</xref>
<xref rid="B40" ref-type="bibr">40</xref>
]. Their support makes it possible to fund implementation of the four components of the SAFE strategy, including the payment of salaries, transportation, drugs, housing and costs for planning and executing mass drug distribution. In this context, social research tools that clarify the relationships, rules and processes among individuals within institutions suggest that the reciprocal actions clustered into enclaves of the like-minded with those sharing the same views may crystallize in a multi-organizational state (donor, university, non-governmental organizations, etc.) where anything outside the limited opinion of nominators, nominees and genitors becomes troublesome (scholasticism) [
<xref rid="B66" ref-type="bibr">66</xref>
,
<xref rid="B67" ref-type="bibr">67</xref>
]. Bringing qualified experts together has led to the assumption that good decisions will result from the groupthink that may emerge in cohesive groups working under conditions of directive leadership to support the views advocated by leaders [
<xref rid="B67" ref-type="bibr">67</xref>
]. These social products display a strong
<italic></italic>
confirmation bias
<italic></italic>
in that they focus on information that confirms initial opinions, and, with a sense of invulnerability, groupthink rebukes different opinions and points of view [
<xref rid="B67" ref-type="bibr">67</xref>
,
<xref rid="B68" ref-type="bibr">68</xref>
]. In addition, the human structures producing and perpetuating concepts that reproduce answers from a set of axioms (possibly resulting in refractive behavior while facing evidence) are labelled by social sciences as scholastic [
<xref rid="B68" ref-type="bibr">68</xref>
]. Accordingly, the repeated antibiotic treatments to kill antibiotic-susceptible bacteria could be seen as the product of scholastic structures confining the good intentions of donors within internal information networks, from which members obtain knowledge reinforcement and legitimization that promotes the
<italic>status-quo</italic>
. Finally, it is pertinent here to include social-psychology approaches that describe human beings as frequently averse to acting contrary to the trend of a group due to fear that the group will express negative attitudes towards them or even exclude them [
<xref rid="B69" ref-type="bibr">69</xref>
,
<xref rid="B70" ref-type="bibr">70</xref>
]. Out of deference to authority and a desire to maintain a harmonious working environment and order to achieve unity of purpose and act as a single entity, members may suppress their concerns and meaningful criticism about dogmas and practices [
<xref rid="B66" ref-type="bibr">66</xref>
].</p>
</sec>
<sec>
<title>Exploring Attitude</title>
<p id="p014">Consequently, hegemonic ways of thinking may have been legitimated and transformed into governmental actions without substantial questioning. Concepts and actions were built in a context in which the people implicated in decisions about workers’ future and careers may have been affected by those they named or funded. In the same intricate arena, it is surprising that members from certain organizations often evaluate the activities of those that fund them and vice versa, with a similar functional structure for reciprocal interactions between researchers and those judging the appropriateness, pertinence and quality of their work [
<xref rid="B71" ref-type="bibr">71</xref>
<xref rid="B73" ref-type="bibr">73</xref>
]. Under these circumstances, disruptive issues are ignored or become homogenized into acceptable terms by previous concepts [
<xref rid="B74" ref-type="bibr">74</xref>
]. Sociology research warns of the danger of abstaining from proper actions if the same elements simultaneously or successively play the role of judge, party, fundraiser, nominee, nominator, employee, employer, fund distributor, employee, manager, researcher, researcher evaluator, publisher and editor [
<xref rid="B75" ref-type="bibr">75</xref>
<xref rid="B77" ref-type="bibr">77</xref>
].</p>
<p id="p015">So far, the reluctance to see disappointing outcomes (after repeated pharmacologic and awareness interventions) hampers further discussion and encourages silence for the sake of harmonious working environment and consensual tendencies in inbred organizations [
<xref rid="B67" ref-type="bibr">67</xref>
,
<xref rid="B74" ref-type="bibr">74</xref>
,
<xref rid="B75" ref-type="bibr">75</xref>
]. In sociology, the term “inbred” is a metaphor connoting an act of incest, the difference being that it is conducted to preserve “desirable” achievements [
<xref rid="B78" ref-type="bibr">78</xref>
,
<xref rid="B79" ref-type="bibr">79</xref>
].</p>
</sec>
<sec>
<title>Elimination of Preventable Blindness from Bacterial Origin: The Urgent Need for Basic Education</title>
<p id="p016">It should be emphasized that public and private institutions fighting against diseases must be supported unconditionally if they operate with open-mindedness and receptiveness to diversity (the remedy to recalcitrant decisions, dogma, groupthink and silence). Therefore, the present analysis does not recommend simple opposition to expert organizations; rather the aim is to understand fundamental assumptions and to prevent institutional productions from being taken for granted. In view of the evidence that the SAFE components may have produced equivalent health improvements through basic schooling (reading, writing, logic analysis and calculation skills) [
<xref rid="B51" ref-type="bibr">51</xref>
<xref rid="B54" ref-type="bibr">54</xref>
], it is time to underline (beyond the scope of ophthalmologists, microbiologists and epidemiologists) the need to assess the limits of the components of the current elimination strategies because the global picture shows that:</p>
<list list-type="simple">
<list-item>
<label>a) </label>
<p id="p017">repeated awareness campaigns to improve hygiene according to the SAFE strategy may not produce irreversible behavior changes;</p>
</list-item>
<list-item>
<label>b) </label>
<p id="p018">hygienic improvements cannot be conclusively transmitted only by medical approaches;</p>
</list-item>
<list-item>
<label>c) </label>
<p id="p019">short-term visits to the affected populations during the implementation of the SAFE strategy are insufficient to ensure the integration of knowledge;</p>
</list-item>
<list-item>
<label>d) </label>
<p id="p020">microbiological approaches are disconnected with the reality of illiterate people;</p>
</list-item>
<list-item>
<label>e) </label>
<p id="p021">social sciences offer vital tools for the assessment, diagnosis, knowledge and reconstruction of the dysfunctional practices (scholasticism, dogma, silence, groupthink, inbred) [
<xref rid="B65" ref-type="bibr">65</xref>
<xref rid="B68" ref-type="bibr">68</xref>
,
<xref rid="B80" ref-type="bibr">80</xref>
];</p>
</list-item>
<list-item>
<label>f) </label>
<p id="p022">antibiotics may eliminate trachoma when associated with basic educational actions [
<xref rid="B81" ref-type="bibr">81</xref>
].</p>
</list-item>
</list>
<p id="p023">In conclusion, the limited success of medical interventions in eliminating transmissible diseases in neglected populations raises an urgent need for interagency engagements advocating basic education programs [
<xref rid="B43" ref-type="bibr">43</xref>
].</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="webpage" publication-format="online">Trachoma. World Health Organization Homepage. Available:
<uri xlink:type="simple" xlink:href="http://www.who.int/topics/trachoma/en/">http://www.who.int/topics/trachoma/en/</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="webpage" publication-format="online">The International Coalition for Trachoma Control (ICTC). Available:
<uri xlink:type="simple" xlink:href="http://www.trachomacoalition.org/">http://www.trachomacoalition.org/</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ngondi</surname>
<given-names>J</given-names>
</name>
,
<name>
<surname>Reacher</surname>
<given-names>M</given-names>
</name>
,
<name>
<surname>Matthews</surname>
<given-names>F</given-names>
</name>
,
<etal>et al.</etal>
</person-group>
<article-title>Trachoma survey methods: a literature review</article-title>
.
<source>Bull World Health Organ</source>
<year>2009</year>
;
<volume>87</volume>
:
<fpage>143</fpage>
<lpage>151</lpage>
.
<pub-id pub-id-type="pmid">19274367</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldschmidt</surname>
<given-names>P</given-names>
</name>
,
<name>
<surname>Rostane</surname>
<given-names>H</given-names>
</name>
,
<name>
<surname>Sow</surname>
<given-names>M</given-names>
</name>
,
<etal>et al.</etal>
</person-group>
<article-title>Detection by broad-range real-time PCR assay of Chlamydia species infecting human and animals</article-title>
.
<source>Br J Ophthalmol</source>
<year>2006</year>
;
<volume>90</volume>
:
<fpage>1425</fpage>
<lpage>1429</lpage>
.
<pub-id pub-id-type="pmid">16899531</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="webpage">Blinding trachoma: Progress towards global elimination by 2020. Report of the 17th meeting of the WHO Alliance for the Global Elimination of Blinding Trachoma.
<uri xlink:type="simple" xlink:href="http://www.who.int/blindness/publications/GET17Report_final.pdf">http://www.who.int/blindness/publications/GET17Report_final.pdf</uri>
[accessed May 26 2015].</mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barr</surname>
<given-names>K</given-names>
</name>
,
<name>
<surname>Essex</surname>
<given-names>RW</given-names>
</name>
,
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
,
<etal>et al.</etal>
</person-group>
<article-title>Comparison of trichiasis recurrence after primary bilamellar tarsal rotation or anterior lamellar repositioning surgery performed for trachoma</article-title>
.
<source>Clin Experiment Ophthalmol</source>
<year>2014</year>
;
<volume>42</volume>
(
<issue>4</issue>
):
<fpage>311</fpage>
<lpage>316</lpage>
.
<pub-id pub-id-type="pmid">23952906</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>West</surname>
<given-names>S</given-names>
</name>
,
<name>
<surname>Munoz</surname>
<given-names>B</given-names>
</name>
,
<name>
<surname>Mkocha</surname>
<given-names>H</given-names>
</name>
,
<etal>et al.</etal>
</person-group>
<article-title>Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study</article-title>
.
<source>Lancet</source>
<year>2005</year>
;
<volume>366</volume>
:
<fpage>1296</fpage>
<lpage>1300</lpage>
.
<pub-id pub-id-type="pmid">16214600</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lietman</surname>
<given-names>TM</given-names>
</name>
,
<name>
<surname>Gebre</surname>
<given-names>T</given-names>
</name>
,
<name>
<surname>Ayele</surname>
<given-names>B</given-names>
</name>
,
<etal>et al.</etal>
</person-group>
<article-title>The epidemiological dynamics of infectious trachoma may facilitate elimination</article-title>
.
<source>Epidemics</source>
<year>2011</year>
;
<volume>3</volume>
:
<fpage>119</fpage>
<lpage>124</lpage>
.
<pub-id pub-id-type="pmid">21624783</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdou</surname>
<given-names>A</given-names>
</name>
,
<name>
<surname>Munoz</surname>
<given-names>B</given-names>
</name>
,
<name>
<surname>Nassirou</surname>
<given-names>B</given-names>
</name>
,
<etal>et al.</etal>
</person-group>
<article-title>How much is not enough? A community randomized trial of a Water and Health Education programme for Trachoma and Ocular C. trachomatis infection in Niger</article-title>
.
<source>Trop Med Int Health</source>
<year>2010</year>
;
<volume>15</volume>
:
<fpage>98</fpage>
<lpage>104</lpage>
.
<pub-id pub-id-type="pmid">20409284</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gambhir</surname>
<given-names>M</given-names>
</name>
,
<name>
<surname>Basáñez</surname>
<given-names>MG</given-names>
</name>
,
<name>
<surname>Blake</surname>
<given-names>IM</given-names>
</name>
,
<etal>et al.</etal>
</person-group>
<article-title>Modelling trachoma for control programmes</article-title>
.
<source>Adv Exp Med Biol</source>
<year>2010</year>
;
<volume>673</volume>
:
<fpage>141</fpage>
<lpage>156</lpage>
.
<pub-id pub-id-type="pmid">20632535</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lavett</surname>
<given-names>D</given-names>
</name>
,
<name>
<surname>Lansingh</surname>
<given-names>V</given-names>
</name>
,
<name>
<surname>Carter</surname>
<given-names>M</given-names>
</name>
,
<etal>et al.</etal>
</person-group>
<article-title>Will the SAFE strategy be sufficient to eliminate trachoma by 2020? Puzzlements and possible solutions</article-title>
.
<source>Scientific World Journal</source>
<year>2013</year>
;
<volume>2013</volume>
:
<fpage>648106</fpage>
.
<pub-id pub-id-type="pmid">23766701</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<mixed-citation publication-type="webpage" publication-format="online">Tips for Deducting Charitable Contribution. Available:
<uri xlink:type="simple" xlink:href="http://www.irs.gov/uac/Eight-Tips-for-Deducting-Charitable-Contributions">http://www.irs.gov/uac/Eight-Tips-for-Deducting-Charitable-Contributions</uri>
. [accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B13">
<label>13</label>
<mixed-citation publication-type="webpage" publication-format="online">Report of the 17th meeting of the WHO Alliance for the Global Elimination of Blinding Trachoma, Geneva, 22–24 April 2013. Geneva: World Health Organization. Available:
<uri xlink:type="simple" xlink:href="http://www.who.int/blindness/publications/GET17Report_final.pdf">http://www.who.int/blindness/publications/GET17Report_final.pdf</uri>
) [accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B14">
<label>14</label>
<mixed-citation publication-type="webpage" publication-format="online">United Nations program to end open defecation. Available:
<uri xlink:type="simple" xlink:href="http://www.un.org/millenniumgoals/endopendefecation.shtml">http://www.un.org/millenniumgoals/endopendefecation.shtml</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B15">
<label>15</label>
<mixed-citation publication-type="webpage" publication-format="online">United Nations General Assembly. Supportive Environments for Healthy Communities. Available:
<uri xlink:type="simple" xlink:href="http://www.washplus.org/">http://www.washplus.org/</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B16">
<label>16</label>
<mixed-citation publication-type="webpage" publication-format="online">WHO/United Nations Children’s Fund and World Health Organization Joint Monitoring Programme for Water Supply and Sanitation towards the Millennium Development Goal (MDG) relating to drinking-water and sanitation. Available:
<uri xlink:type="simple" xlink:href="http://www.wssinfo.org/definitions-methods">http://www.wssinfo.org/definitions-methods</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B17">
<label>17</label>
<mixed-citation publication-type="webpage" publication-format="online">United Nations Children’s Fund and World Health Organization, WHO/UNICEF Joint Statement. Clinical management of acute diarrhoea’, UNICEF, New York, 2004. Available:
<uri xlink:type="simple" xlink:href="http://www.afro.who.int/cah/documents/intervention/acute_diarrhoea_joint_statement.pdf">http://www.afro.who.int/cah/documents/intervention/acute_diarrhoea_joint_statement.pdf</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B18">
<label>18</label>
<mixed-citation publication-type="webpage" publication-format="online">Trachoma USAID. Available:
<uri xlink:type="simple" xlink:href="http://www.usaid.gov/news-information/frontlines/water-neglected-tropical-diseases/trachoma-vs-technology">http://www.usaid.gov/news-information/frontlines/water-neglected-tropical-diseases/trachoma-vs-technology</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B19">
<label>19</label>
<mixed-citation publication-type="webpage" publication-format="online">Fast Track Initiative to Eliminate Blinding Trachoma. ICTC Sightsavers 2011. Available:
<uri xlink:type="simple" xlink:href="http://www.sightsavers.net/in_depth/policy_and_research/health/17009_A%20SAFE%20solution%20low%20res%20version.pdf">http://www.sightsavers.net/in_depth/policy_and_research/health/17009_A%20SAFE%20solution%20low%20res%20version.pdf</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B20">
<label>20</label>
<mixed-citation publication-type="webpage" publication-format="online">Global Trachoma Mapping Consortium. Sightsavers. Available:
<uri xlink:type="simple" xlink:href="http://www.sightsavers.org/our_work/how_we_work/partnership/18687.html">http://www.sightsavers.org/our_work/how_we_work/partnership/18687.html</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B21">
<label>21</label>
<mixed-citation publication-type="webpage">The Queen Elizabeth Diamond Jubilee Trust. Available:
<uri xlink:type="simple" xlink:href="https://www.sightsavers.org/about_us/media_centre/press_releases/18462.html">https://www.sightsavers.org/about_us/media_centre/press_releases/18462.html</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B22">
<label>22</label>
<mixed-citation publication-type="webpage">Sight savers International: Vision for a village. Available:
<uri xlink:type="simple" xlink:href="www.sightsavers.org">www.sightsavers.org</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B23">
<label>23</label>
<mixed-citation publication-type="webpage" publication-format="online">The Lions Save Sight Foundation. Available:
<uri xlink:type="simple" xlink:href="http://www.lionssavesightfoundation.org">http://www.lionssavesightfoundation.org</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B24">
<label>24</label>
<mixed-citation publication-type="webpage" publication-format="online">The Carter Center: Trachoma Control Program. Available:
<uri xlink:type="simple" xlink:href="http://cartercenter.org/health/trachoma/index.html">http://cartercenter.org/health/trachoma/index.html</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B25">
<label>25</label>
<mixed-citation publication-type="webpage" publication-format="online">Christian Blind Mission International (CBMI). Available:
<uri xlink:type="simple" xlink:href="http://www.trachomacoalition.org/about-us/members/cbm">http://www.trachomacoalition.org/about-us/members/cbm</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B26">
<label>26</label>
<mixed-citation publication-type="webpage" publication-format="online">Helen Keller International. Available:
<uri xlink:type="simple" xlink:href="http://www.hki.org/our-work/eliminating-diseases-poverty/trachoma">http://www.hki.org/our-work/eliminating-diseases-poverty/trachoma</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B27">
<label>27</label>
<mixed-citation publication-type="webpage" publication-format="online">ORBIS International Coalition for Trachoma control. Available:
<uri xlink:type="simple" xlink:href="http://www.trachomacoalition.org/about-us/members/orbis-international">http://www.trachomacoalition.org/about-us/members/orbis-international</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B28">
<label>28</label>
<mixed-citation publication-type="webpage" publication-format="online">Pfizer Global Health Programs. Available:
<uri xlink:type="simple" xlink:href="http://www.pfizer.com/responsibility/global_health/international_trachoma_initiative">http://www.pfizer.com/responsibility/global_health/international_trachoma_initiative</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B29">
<label>29</label>
<mixed-citation publication-type="webpage" publication-format="online">Hygiene-related Diseases. Available:
<uri xlink:type="simple" xlink:href="http://www.cdc.gov/healthywater/hygiene/disease/trachoma.html">http://www.cdc.gov/healthywater/hygiene/disease/trachoma.html</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B30">
<label>30</label>
<mixed-citation publication-type="webpage" publication-format="online">Human right to water and sanitation: International Decade. Available:
<uri xlink:type="simple" xlink:href="http://www.un.org/waterforlifedecade/human_right_to_water">http://www.un.org/waterforlifedecade/human_right_to_water</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B31">
<label>31</label>
<mixed-citation publication-type="webpage" publication-format="online">Neglected Tropical Disease NGDO Network. Available:
<uri xlink:type="simple" xlink:href="http://unitingtocombatntds.org/endorsement/neglected-tropical-disease-ngdo-network">http://unitingtocombatntds.org/endorsement/neglected-tropical-disease-ngdo-network</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B32">
<label>32</label>
<mixed-citation publication-type="webpage">World Vision International. Available:
<uri xlink:type="simple">info@visiondumonde.fr</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B33">
<label>33</label>
<mixed-citation publication-type="webpage" publication-format="online">Organisation pour la Prévention de la Cécité. Available:
<uri xlink:type="simple" xlink:href="http://www.opc.asso.fr/">http://www.opc.asso.fr/</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B34">
<label>34</label>
<mixed-citation publication-type="webpage" publication-format="online">The International Agency for the Prevention of Blindness. Available:
<uri xlink:type="simple" xlink:href="http://www.iapb.org/">http://www.iapb.org/</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B35">
<label>35</label>
<mixed-citation publication-type="webpage" publication-format="online">Light For the World. Available:
<uri xlink:type="simple" xlink:href="http://www.light-for-the-world.org/">http://www.light-for-the-world.org/</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B36">
<label>36</label>
<mixed-citation publication-type="webpage" publication-format="online">Eyes For The World. Available:
<uri xlink:type="simple" xlink:href="http://www.eyesfortheworld.be/en/index.html">http://www.eyesfortheworld.be/en/index.html</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B37">
<label>37</label>
<mixed-citation publication-type="webpage" publication-format="online">The Fred Hollows Foundation, New Zealand. Available:
<uri xlink:type="simple" xlink:href="http://www.hollows.org.nz/">http://www.hollows.org.nz/</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B38">
<label>38</label>
<mixed-citation publication-type="webpage" publication-format="online">Lions Clubs Sight Programs to Prevent Blindness. Available:
<uri xlink:type="simple" xlink:href="http://www.lionsclubs.org/EN/our-work/sight-programs/">http://www.lionsclubs.org/EN/our-work/sight-programs/</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B39">
<label>39</label>
<mixed-citation publication-type="webpage">World Vision International for Children, for Change, for Life. Available:
<uri xlink:type="simple" xlink:href="www.wvi.org">www.wvi.org</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B40">
<label>40</label>
<mixed-citation publication-type="webpage" publication-format="online">RTI International. Available:
<uri xlink:type="simple" xlink:href="http://www.rti.org/">http://www.rti.org/</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B41">
<label>41</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matzneller</surname>
<given-names>P</given-names>
</name>
,
<name>
<surname>Krasniqi</surname>
<given-names>S</given-names>
</name>
,
<name>
<surname>Kinzig</surname>
<given-names>M</given-names>
</name>
,
<etal>et al.</etal>
</person-group>
<article-title>Blood, tissue, and intracellular concentrations of azithromycin during and after end of therapy</article-title>
.
<source>Antimicrob Agents Chemother</source>
<year>2013</year>
;
<volume>57</volume>
(
<issue>4</issue>
):
<fpage>1736</fpage>
<lpage>1742</lpage>
.
<pub-id pub-id-type="pmid">23357769</pub-id>
</mixed-citation>
</ref>
<ref id="B42">
<label>42</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burton</surname>
<given-names>MJ</given-names>
</name>
,
<name>
<surname>Frick</surname>
<given-names>KD</given-names>
</name>
,
<name>
<surname>Bailey</surname>
<given-names>RL</given-names>
</name>
,
<etal>et al.</etal>
</person-group>
<article-title>Azithromycin for the treatment and control of trachoma</article-title>
.
<source>Expert Opin Pharmacother</source>
<year>2002</year>
;
<volume>3</volume>
(
<issue>2</issue>
):
<fpage>113</fpage>
<lpage>120</lpage>
.
<pub-id pub-id-type="pmid">11829725</pub-id>
</mixed-citation>
</ref>
<ref id="B43">
<label>43</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldschmidt</surname>
<given-names>P</given-names>
</name>
,
<name>
<surname>Einterz</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>The limits of medical interventions for the elimination of preventable blindness</article-title>
.
<source>Trop Med Health</source>
<year>2014</year>
;
<volume>42</volume>
(
<issue>1</issue>
):
<fpage>43</fpage>
<lpage>52</lpage>
.
<pub-id pub-id-type="pmid">24808746</pub-id>
</mixed-citation>
</ref>
<ref id="B44">
<label>44</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>KC</given-names>
</name>
,
<name>
<surname>Schachter</surname>
<given-names>J</given-names>
</name>
,
<name>
<surname>Moncada</surname>
<given-names>J</given-names>
</name>
,
<etal>et al.</etal>
</person-group>
<article-title>Lack of macrolide resistance in Chlamydia trachomatis after mass azithromycin distributions for trachoma</article-title>
.
<source>Emerg Infect Dis</source>
<year>2009</year>
;
<volume>15</volume>
(
<issue>7</issue>
):
<fpage>1088</fpage>
<lpage>1090</lpage>
.
<pub-id pub-id-type="pmid">19624926</pub-id>
</mixed-citation>
</ref>
<ref id="B45">
<label>45</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhengraj</surname>
<given-names>AR</given-names>
</name>
,
<name>
<surname>Srivastava</surname>
<given-names>P</given-names>
</name>
,
<name>
<surname>Mittal</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Lack of mutation in macrolide resistance genes in Chlamydia trachomatis clinical isolates with decreased susceptibility to azithromycin</article-title>
.
<source>Int J Antimicrob Agents</source>
<year>2011</year>
;
<volume>38</volume>
(
<issue>2</issue>
):
<fpage>178</fpage>
<lpage>179</lpage>
.
<pub-id pub-id-type="pmid">21570258</pub-id>
</mixed-citation>
</ref>
<ref id="B46">
<label>46</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Card</surname>
<given-names>RM</given-names>
</name>
,
<name>
<surname>Warburton</surname>
<given-names>PJ</given-names>
</name>
,
<name>
<surname>Maclaren</surname>
<given-names>N</given-names>
</name>
,
<etal>et al.</etal>
</person-group>
<article-title>Application of microarray and functional-based screening methods for the detection of antimicrobial resistance genes in the microbiomes of healthy humans</article-title>
.
<source>PLoS One</source>
<year>2014</year>
;
<volume>9</volume>
(
<issue>1</issue>
):
<fpage>e86428</fpage>
.
<pub-id pub-id-type="pmid">24466089</pub-id>
</mixed-citation>
</ref>
<ref id="B47">
<label>47</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roba</surname>
<given-names>A</given-names>
</name>
,
<name>
<surname>Patel</surname>
<given-names>D</given-names>
</name>
,
<name>
<surname>Zondervan</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Risk of trachoma in a SAFE intervention area</article-title>
.
<source>Int Ophthalmol</source>
<year>2013</year>
;
<volume>33</volume>
:
<fpage>53</fpage>
<lpage>59</lpage>
.
<pub-id pub-id-type="pmid">23053768</pub-id>
</mixed-citation>
</ref>
<ref id="B48">
<label>48</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evans</surname>
<given-names>JR</given-names>
</name>
,
<name>
<surname>Solomon</surname>
<given-names>AW</given-names>
</name>
</person-group>
<article-title>Antibiotics for trachoma</article-title>
.
<source>Cochrane Database Syst Rev.</source>
<year>2011</year>
Mar 16; (3):
<fpage>CD001860</fpage>
.
<pub-id pub-id-type="pmid">21412875</pub-id>
</mixed-citation>
</ref>
<ref id="B49">
<label>49</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Munoz</surname>
<given-names>B</given-names>
</name>
,
<name>
<surname>Stare</surname>
<given-names>D</given-names>
</name>
,
<name>
<surname>Mkocha</surname>
<given-names>H</given-names>
</name>
,
<etal>et al.</etal>
</person-group>
<article-title>Can clinical signs of trachoma be used after multiple rounds of mass antibiotic treatment to indicate infection?</article-title>
<source>Invest Ophthalmol Vis Sci</source>
<year>2011</year>
;
<volume>52</volume>
:
<fpage>8806</fpage>
<lpage>8810</lpage>
.
<pub-id pub-id-type="pmid">22025578</pub-id>
</mixed-citation>
</ref>
<ref id="B50">
<label>50</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stoller</surname>
<given-names>N</given-names>
</name>
,
<name>
<surname>Gebre</surname>
<given-names>T</given-names>
</name>
,
<name>
<surname>Ayele</surname>
<given-names>B</given-names>
</name>
,
<etal>et al.</etal>
</person-group>
<article-title>Efficacy of latrine promotion on emergence of infection with ocular Chlamydia trachomatis after mass antibiotic treatment: a cluster-randomized trial</article-title>
.
<source>Int Health</source>
<year>2011</year>
;
<volume>3</volume>
:
<fpage>75</fpage>
<lpage>84</lpage>
.
<pub-id pub-id-type="pmid">21785663</pub-id>
</mixed-citation>
</ref>
<ref id="B51">
<label>51</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dolin</surname>
<given-names>P</given-names>
</name>
,
<name>
<surname>Faal</surname>
<given-names>H</given-names>
</name>
,
<name>
<surname>Johnson</surname>
<given-names>GJ</given-names>
</name>
,
<etal>et al.</etal>
</person-group>
<article-title>Reduction of trachoma in a sub-Saharan village in absence of a disease control programme</article-title>
.
<source>Lancet</source>
<year>1997</year>
;
<volume>3494</volume>
:
<fpage>1511</fpage>
<lpage>1512</lpage>
.
<pub-id pub-id-type="pmid">9167460</pub-id>
</mixed-citation>
</ref>
<ref id="B52">
<label>52</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burton</surname>
<given-names>M</given-names>
</name>
,
<name>
<surname>Holland</surname>
<given-names>M</given-names>
</name>
,
<name>
<surname>Makalo</surname>
<given-names>P</given-names>
</name>
,
<etal>et al.</etal>
</person-group>
<article-title>Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities</article-title>
.
<source>PLoS Negl Trop Dis</source>
<year>2010</year>
;
<volume>5</volume>
; 4(
<issue>10</issue>
). pii: e835.</mixed-citation>
</ref>
<ref id="B53">
<label>53</label>
<mixed-citation publication-type="webpage" publication-format="online">Bougroum M, Wade Diagne A, Kissami A, et al. 2007. Literacy Policies and Strategies in the Maghreb: Comparative Perspectives from Algeria, Mauritania and Morocco. Available:
<uri xlink:type="simple" xlink:href="http://unesco.atlasproject.eu/search_results">http://unesco.atlasproject.eu/search_results</uri>
.</mixed-citation>
</ref>
<ref id="B54">
<label>54</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yee</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Nepal sees end in sight for trachoma</article-title>
.
<source>Lancet</source>
<year>2012</year>
;
<volume>379</volume>
:
<fpage>2329</fpage>
<lpage>2330</lpage>
.
<pub-id pub-id-type="pmid">22734144</pub-id>
</mixed-citation>
</ref>
<ref id="B55">
<label>55</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ejere</surname>
<given-names>HO</given-names>
</name>
,
<name>
<surname>Alhassan</surname>
<given-names>MB</given-names>
</name>
,
<name>
<surname>Rabiu</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Face washing promotion for preventing active trachoma</article-title>
.
<source>Cochrane Database Syst Rev</source>
<year>2012</year>
;
<volume>4</volume>
:
<fpage>CD003659</fpage>
.
<pub-id pub-id-type="pmid">22513915</pub-id>
</mixed-citation>
</ref>
<ref id="B56">
<label>56</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Travers</surname>
<given-names>A</given-names>
</name>
,
<name>
<surname>Strasser</surname>
<given-names>S</given-names>
</name>
,
<name>
<surname>Palmer</surname>
<given-names>SL</given-names>
</name>
,
<etal>et al.</etal>
</person-group>
<article-title>The added value of water, sanitation, and hygiene interventions to mass drug administration for reducing the prevalence of trachoma: a systematic review examining</article-title>
.
<source>J Environ Public Health</source>
<year>2013</year>
: 682093.</mixed-citation>
</ref>
<ref id="B57">
<label>57</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiesecker</surname>
<given-names>J</given-names>
</name>
,
<name>
<surname>Skelly</surname>
<given-names>D</given-names>
</name>
,
<name>
<surname>Beard</surname>
<given-names>K</given-names>
</name>
,
<etal>et al.</etal>
</person-group>
<article-title>Behavioral reduction of infection risk</article-title>
.
<source>Proc Natl Acad Sci U S A</source>
<year>1999</year>
;
<volume>96</volume>
:
<fpage>9165</fpage>
<lpage>9168</lpage>
.
<pub-id pub-id-type="pmid">10430913</pub-id>
</mixed-citation>
</ref>
<ref id="B58">
<label>58</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lomas</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Social Capital and Health: Implications for Public Health and Epidemiology</article-title>
.
<source>Soc Sci Med</source>
<year>1998</year>
;
<volume>47</volume>
:
<fpage>1181</fpage>
<lpage>1188</lpage>
.
<pub-id pub-id-type="pmid">9783861</pub-id>
</mixed-citation>
</ref>
<ref id="B59">
<label>59</label>
<mixed-citation publication-type="book">Knowles M. The Adult Learner: A Neglected Species. Gulf Publishing Company, Book Division; 1978; Houston, TX 7700, USA.</mixed-citation>
</ref>
<ref id="B60">
<label>60</label>
<mixed-citation publication-type="book">Cross, K. Adults as Learners. Increasing participation and facilitating learning. San Francisco, USA: Jossey-Bass Ed.; 1992.</mixed-citation>
</ref>
<ref id="B61">
<label>61</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devisch</surname>
<given-names>I</given-names>
</name>
,
<name>
<surname>Murray</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>We hold these truths to be self-evident: deconstructing evidence-based medical practice</article-title>
.
<source>J Eval Clin Pract</source>
<year>2009</year>
;
<volume>15</volume>
:
<fpage>950</fpage>
<lpage>954</lpage>
.
<pub-id pub-id-type="pmid">20367689</pub-id>
</mixed-citation>
</ref>
<ref id="B62">
<label>62</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rabiu</surname>
<given-names>M</given-names>
</name>
,
<name>
<surname>Alhassan</surname>
<given-names>M</given-names>
</name>
,
<name>
<surname>Ejere</surname>
<given-names>H</given-names>
</name>
, et al.</person-group>
<article-title>Environmental Sanitary Interventions for Preventing Active Trachoma</article-title>
.
<source>Cochrane Database Syst Rev</source>
<year>2012</year>
15; 2: CD004003.</mixed-citation>
</ref>
<ref id="B63">
<label>63</label>
<mixed-citation publication-type="book">Solomon A, Zondervan M, Kuper H, et al. Trachoma Control: A Guide for Programme Managers. Geneva: World Health Organization; 2006.</mixed-citation>
</ref>
<ref id="B64">
<label>64</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sigdel</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Role of Medical Sociology and Anthropology in Public Health and Health System Development</article-title>
.
<source>Health Prospect</source>
<year>2012</year>
;
<volume>11</volume>
:
<fpage>28</fpage>
<lpage>29</lpage>
.</mixed-citation>
</ref>
<ref id="B65">
<label>65</label>
<mixed-citation publication-type="book">Cockerham WC. Medical Sociology, 8th edition. Englewood Cliffs, NJ: Prentice Hall, USA; 2000.</mixed-citation>
</ref>
<ref id="B66">
<label>66</label>
<mixed-citation publication-type="book">Janis I. Victims of Groupthink. Boston: Houghton-Mifflin; 1972.</mixed-citation>
</ref>
<ref id="B67">
<label>67</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harvey</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The Abilene Paradox: The Management of Agreement</article-title>
.
<source>Organizational Development</source>
<year>1974</year>
;
<volume>22</volume>
:
<fpage>17</fpage>
<lpage>34</lpage>
.</mixed-citation>
</ref>
<ref id="B68">
<label>68</label>
<mixed-citation publication-type="book">Secada J. Cartesian Metaphysics: The Late Scholastic Origins of Modern Philosophy. England: Cambridge University Press; 2000.</mixed-citation>
</ref>
<ref id="B69">
<label>69</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hart</surname>
<given-names>E</given-names>
</name>
,
<name>
<surname>Hazelgrove</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Understanding the Organizational Context for Adverse Events in the Health Services: The Role of Cultural Censorship</article-title>
.
<source>Qual Health Care</source>
<year>2001</year>
;
<volume>10</volume>
:
<fpage>257</fpage>
<lpage>262</lpage>
.
<pub-id pub-id-type="pmid">11743156</pub-id>
</mixed-citation>
</ref>
<ref id="B70">
<label>70</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horta</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Deepening our understanding of academic inbreeding effects on research information exchange and scientific output: new insights for academic based research</article-title>
.
<source>Hig Educ</source>
<year>2013</year>
;
<volume>65</volume>
(
<issue>4</issue>
):
<fpage>487</fpage>
<lpage>510</lpage>
.</mixed-citation>
</ref>
<ref id="B71">
<label>71</label>
<mixed-citation publication-type="book">Alston LJ, Eggerston T, North DC. Empirical Studies of Organizational Change. England: Cambridge University Press; 1996.</mixed-citation>
</ref>
<ref id="B72">
<label>72</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langfeldt</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>The policy challenges of peer review: managing bias, conflict of interests and interdisciplinary assessments</article-title>
.
<source>Research Evaluation</source>
<year>2006</year>
;
<volume>15</volume>
:
<fpage>31</fpage>
<lpage>41</lpage>
.</mixed-citation>
</ref>
<ref id="B73">
<label>73</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boix-Mansilla</surname>
<given-names>V</given-names>
</name>
,
<name>
<surname>Feller</surname>
<given-names>I</given-names>
</name>
,
<name>
<surname>Gardner</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Quality assessment in interdisciplinary research and education</article-title>
.
<source>Research Evaluation</source>
<year>2006</year>
;
<volume>15</volume>
:
<fpage>69</fpage>
<lpage>74</lpage>
.</mixed-citation>
</ref>
<ref id="B74">
<label>74</label>
<mixed-citation publication-type="book">Page S. The difference: how the power of diversity creates better groups, firms, schools, and societies. Princeton University Press 2007. Princeton, USA ISBN: 9780691128382</mixed-citation>
</ref>
<ref id="B75">
<label>75</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patterson</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Harmony through diversity: exploring the ecosystem paradigm for higher education</article-title>
.
<source>Journal of Higher Education Policy and Management</source>
<year>2004</year>
;
<volume>26</volume>
(
<issue>1</issue>
):
<fpage>60</fpage>
<lpage>74</lpage>
.</mixed-citation>
</ref>
<ref id="B76">
<label>76</label>
<mixed-citation publication-type="webpage" publication-format="online">Ostrom Elinor. Understanding Institutional Diversity. 2005. Princeton University Press.
<uri xlink:type="simple" xlink:href="http://press.princeton.edu/chapters/s8085.pdf">http://press.princeton.edu/chapters/s8085.pdf</uri>
. ISBN: 9781400831739 [accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B77">
<label>77</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basak</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>An ethical issue-Academic incest: Maintaining status quo in higher education</article-title>
.
<source>International Journal of New Trends in Arts, Sports & Science Education</source>
<year>2013</year>
;
<volume>2</volume>
(
<issue>4</issue>
):
<fpage>28</fpage>
<lpage>32</lpage>
.</mixed-citation>
</ref>
<ref id="B78">
<label>78</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grossman</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>The perverse attitude toward reality</article-title>
.
<source>Psychoanal Q</source>
<year>1993</year>
;
<volume>62</volume>
(
<issue>3</issue>
):
<fpage>422</fpage>
<lpage>436</lpage>
. Available: www.ncbi.nlm.nih.gov/pubmed/8416029 [accessed March 3, 2015]
<pub-id pub-id-type="pmid">8416029</pub-id>
</mixed-citation>
</ref>
<ref id="B79">
<label>79</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stein</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Why perversion?: ‘False love’ and the perverse pact</article-title>
.
<source>Int J Psychoanal</source>
<year>2005</year>
;
<volume>86</volume>
(
<issue>3</issue>
):
<fpage>776</fpage>
<lpage>799</lpage>
.
<pub-id pub-id-type="pmid">16096075</pub-id>
</mixed-citation>
</ref>
<ref id="B80">
<label>80</label>
<mixed-citation publication-type="webpage" publication-format="online">Haberman M. The Pedagogy of Poverty Versus Good Teaching. 1991; ISSN-0031-7217. Available:
<uri xlink:type="simple" xlink:href="http://www.educationnews.org/ed_reports/32472.html">http://www.educationnews.org/ed_reports/32472.html</uri>
[accessed March 3, 2015]</mixed-citation>
</ref>
<ref id="B81">
<label>81</label>
<mixed-citation publication-type="book">Weick K. The Reduction of Medical Errors through Mindful Interdependence. In: Rosenthal MM, Sutcliffe KM, eds. Medical Error: What Do We Know? What Do We Do? San Francisco: Jossey-Bass; 2002. pp 177–199.</mixed-citation>
</ref>
</ref-list>
</back>
<floats-group>
<table-wrap id="T1" orientation="portrait" position="float">
<label>Table 1.</label>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th rowspan="1" colspan="1">Organization</th>
<th rowspan="1" colspan="1">Activities</th>
<th rowspan="1" colspan="1">Website/Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="1" colspan="1">The World Health Organization (WHO)</td>
<td rowspan="1" colspan="1">associates the Alliance for the Global Elimination of Blinding Trachoma by the Year 2020 (GET2020) with the Trachoma Scientific Informal Workshop (TSIW) for the implementation of the SAFE strategy.</td>
<td rowspan="1" colspan="1">[
<xref rid="B2" ref-type="bibr">2</xref>
,
<xref rid="B13" ref-type="bibr">13</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">The United Nations (UN) Secretary-General’s campaign to end open defecation by 2025</td>
<td rowspan="1" colspan="1">provides opportunities for synergy with trachoma control activities according to the SAFE strategy</td>
<td rowspan="1" colspan="1">[
<xref rid="B14" ref-type="bibr">14</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">The UN General Assembly</td>
<td rowspan="1" colspan="1">advocates the right to safe drinking water and sanitation (UN General Assembly resolution A/RES/64/292).</td>
<td rowspan="1" colspan="1">[
<xref rid="B15" ref-type="bibr">15</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">WHO/United Nations Children’s Fund (UNICEF) Joint Monitoring Programme for Water Supply and Sanitation</td>
<td rowspan="1" colspan="1">advocates access to drinking water and sanitation</td>
<td rowspan="1" colspan="1">[
<xref rid="B16" ref-type="bibr">16</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">WHO/UNICEF Integrated Global Action Plan for the Prevention and Control of Pneumonia and Diarrhoea</td>
<td rowspan="1" colspan="1">provides a framework for ministries of health to coordinate goals and targets.</td>
<td rowspan="1" colspan="1">[
<xref rid="B17" ref-type="bibr">17</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">U.S. Agency for International Development (USAID)</td>
<td rowspan="1" colspan="1">participates in scaling up mass drug administration programmes according to the SAFE strategy.</td>
<td rowspan="1" colspan="1">[
<xref rid="B18" ref-type="bibr">18</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">International Coalition for Trachoma Control (ICTC)</td>
<td rowspan="1" colspan="1">supports the 2020 Alliance and advocates the SAFE strategy in the implementation of control programs.</td>
<td rowspan="1" colspan="1">[
<xref rid="B19" ref-type="bibr">19</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Global Trachoma Mapping Consortium (GTMP)</td>
<td rowspan="1" colspan="1">develops WHO protocols for the implementation of the SAFE strategy.</td>
<td rowspan="1" colspan="1">[
<xref rid="B20" ref-type="bibr">20</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">The Queen Elizabeth Diamond Jubilee Trust</td>
<td rowspan="1" colspan="1">participates in the implementation of the components of the SAFE strategy.</td>
<td rowspan="1" colspan="1">[
<xref rid="B21" ref-type="bibr">21</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Sightsavers with support from the British government</td>
<td rowspan="1" colspan="1">is associated with partners on trachoma control according to WHO guidelines.</td>
<td rowspan="1" colspan="1">[
<xref rid="B22" ref-type="bibr">22</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Sight First (Lions Clubs International Foundation)</td>
<td rowspan="1" colspan="1">operates against trachoma following the SAFE elimination strategy</td>
<td rowspan="1" colspan="1">[
<xref rid="B23" ref-type="bibr">23</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">The Carter Center’s Trachoma Control Program</td>
<td rowspan="1" colspan="1">supports trichiasis surgery, participates in the construction of household latrines and assists in health education and mass drug administration of antibiotics.</td>
<td rowspan="1" colspan="1">[
<xref rid="B24" ref-type="bibr">24</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Christian Blind Mission (CBM)</td>
<td rowspan="1" colspan="1">supports the WHO guidelines according to the SAFE strategy components.</td>
<td rowspan="1" colspan="1">[
<xref rid="B25" ref-type="bibr">25</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Helen Keller International</td>
<td rowspan="1" colspan="1">establishes programs based on the SAFE components.</td>
<td rowspan="1" colspan="1">[
<xref rid="B26" ref-type="bibr">26</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Orbis International</td>
<td rowspan="1" colspan="1">works in developing countries through eye care training with local organizations.</td>
<td rowspan="1" colspan="1">[
<xref rid="B27" ref-type="bibr">27</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Pfizer Inc. and the Edna McConnell Clark Foundation</td>
<td rowspan="1" colspan="1">co-established the not-for-profit organization International Trachoma Initiative (ITI) with governmental and nongovernmental agencies to implement the SAFE strategy.</td>
<td rowspan="1" colspan="1">[
<xref rid="B26" ref-type="bibr">26</xref>
,
<xref rid="B28" ref-type="bibr">28</xref>
<xref rid="B29" ref-type="bibr">29</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">The Water, Sanitation and Hygiene program at WHO (WASH organization)</td>
<td rowspan="1" colspan="1">provides support for trachoma elimination programs with particular emphasis on the promotion of behavioral change and the need for a sound evidence base of action.</td>
<td rowspan="1" colspan="1">[
<xref rid="B30" ref-type="bibr">30</xref>
]</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T2" orientation="portrait" position="float">
<label>Table 2.</label>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th rowspan="1" colspan="1">NTD NGDO partners</th>
<th rowspan="1" colspan="1">Activities</th>
<th rowspan="1" colspan="1">Website/Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="1" colspan="1">World Vision International</td>
<td rowspan="1" colspan="1">improves children’s health</td>
<td align="center" rowspan="1" colspan="1">[
<xref rid="B32" ref-type="bibr">32</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Organisation pour la Prévention de la Cécité</td>
<td rowspan="1" colspan="1">assists populations in French-speaking developing countries</td>
<td align="center" rowspan="1" colspan="1">[
<xref rid="B33" ref-type="bibr">33</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">The International Agency for the Prevention of Blindness</td>
<td rowspan="1" colspan="1">leads international efforts in blindness prevention activities, particularly in rural areas.</td>
<td align="center" rowspan="1" colspan="1">[
<xref rid="B34" ref-type="bibr">34</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Light for the World</td>
<td rowspan="1" colspan="1">confederates national development NGOs committed to saving eyesight and improving the quality of life.</td>
<td align="center" rowspan="1" colspan="1">[
<xref rid="B35" ref-type="bibr">35</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Eyes of the World</td>
<td rowspan="1" colspan="1">especially helps children who suffer from poor vision.</td>
<td align="center" rowspan="1" colspan="1">[
<xref rid="B36" ref-type="bibr">36</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">The Fred Hollows Foundation</td>
<td rowspan="1" colspan="1">restores sight and trains eye doctors in developing countries.</td>
<td align="center" rowspan="1" colspan="1">[
<xref rid="B37" ref-type="bibr">37</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">The Eye Mission of the Lions Clubs International Foundation</td>
<td rowspan="1" colspan="1">supports projects to prevent blindness, restore eyesight and improve eye health and eye care.</td>
<td align="center" rowspan="1" colspan="1">[
<xref rid="B38" ref-type="bibr">38</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">World Vision International for Children</td>
<td rowspan="1" colspan="1">works to overcome poverty.</td>
<td align="center" rowspan="1" colspan="1">[
<xref rid="B39" ref-type="bibr">39</xref>
]</td>
</tr>
<tr>
<td colspan="3" rowspan="1">
<hr></hr>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">RTI International (funded by the U.S. Agency for International Development)</td>
<td rowspan="1" colspan="1">provides assistance to NTDs control through the NTD NGDO Program and the ENVISION Project (2011–2016).</td>
<td align="center" rowspan="1" colspan="1">[
<xref rid="B40" ref-type="bibr">40</xref>
]</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/EpistemeV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000017 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000017 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Ticri/CIDE
   |area=    EpistemeV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     PMC:4491490
   |texte=   Social Sciences for the Prevention of Blindness
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i   -Sk "pubmed:26161032" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a EpistemeV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Wed Nov 1 16:34:12 2017. Site generation: Sun Mar 10 15:11:59 2024